Moderate

Gestational diabetes mellitus (GDM)

GDM · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Glucose intolerance first recognised in pregnancy, usually after 24 weeks, driven by placental anti-insulin hormones. Raises risk of macrosomia, shoulder dystocia, neonatal hypoglycaemia and later maternal type 2 diabetes.

Red flags

  • Fasting glucose >=7.0 mmol/L at diagnosis (likely overt diabetes)
  • Fetal macrosomia or polyhydramnios on scan
  • Recurrent maternal hypoglycaemia on insulin
  • Pre-eclampsia features
  • Reduced fetal movements

Assessment

Differential diagnosis

  • Pre-existing undiagnosed type 2 diabetes
  • Pre-existing type 1 diabetes
  • MODY
  • Pancreatic/steroid-induced hyperglycaemia
  • Stress hyperglycaemia

Investigations

  • 75g OGTT at 24-28 weeks (earlier if high risk)
  • Fasting and postprandial capillary glucose monitoring
  • HbA1c at booking to exclude pre-existing diabetes
  • Serial growth ultrasound for fetal size/polyhydramnios
  • Urinalysis for ketones/protein

Management

  • Confirm diagnosis using local thresholds (NICE: fasting >=5.6 or 2h >=7.8 mmol/L; IADPSG: fasting >=5.1, 1h >=10.0, 2h >=8.5)
  • Start dietary/lifestyle advice with dietitian referral and self-monitoring 4x/day
  • Set glucose targets: fasting <5.3, 1h post-meal <7.8 or 2h <6.4 mmol/L
  • Review glucose diary after 1-2 weeks; if targets unmet add metformin
  • Add or switch to insulin if targets still unmet or at presentation with fasting >=7.0 or macrosomia/polyhydramnios
  • Arrange serial growth scans every ~4 weeks from 28-36 weeks
  • Plan birth: offer delivery by 40+6 weeks (earlier if complications)
  • Stop glucose-lowering drugs immediately after delivery
  • Check fasting glucose or HbA1c 6-13 weeks postpartum and annually thereafter
  • Counsel on lifestyle, ~50% lifetime T2DM risk and future pregnancy screening

Drugs & doses

Metformin 500 mg PO once-twice daily, titrate to max 2-2.5 g/day
Insulin isophane/NPH or basal analogue titrated to fasting target
Insulin aspart with meals titrated to postprandial target
Glibenclamide 2.5-5 mg PO if metformin declined and insulin refused

Disposition

Manage in joint diabetes-antenatal clinic; escalate to obstetrics for growth/liquor abnormalities and plan supervised delivery with neonatal availability.

Complications & pitfalls

  • Macrosomia and shoulder dystocia
  • Neonatal hypoglycaemia and jaundice
  • Pre-eclampsia and polyhydramnios
  • Stillbirth
  • Progression to type 2 diabetes

Exam pearls

  • HbA1c is unreliable late in pregnancy due to red cell turnover; use OGTT and self-monitoring
  • Metformin and insulin are both first-line and compatible with breastfeeding
  • A fasting glucose above target is the hardest to control with diet alone
  • Any woman with prior GDM should be screened early in the next pregnancy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.